Single-cell RNA sequencing for the identification of early-stage lung cancer biomarkers from circulating blood

Lung cancer accounts for more than half of the new cancers diagnosed world-wide with poor survival rates. Despite the development of chemical, radiological, and immunotherapies, many patients do not benefit from these therapies, as recurrence is common. We performed single-cell RNA-sequencing (scRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jinhong, Xu, Zhaolin, Marignani, Paola A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519939/
https://www.ncbi.nlm.nih.gov/pubmed/34654834
http://dx.doi.org/10.1038/s41525-021-00248-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519939/
https://www.ncbi.nlm.nih.gov/pubmed/34654834
http://dx.doi.org/10.1038/s41525-021-00248-y

Ejemplares similares